Human Reproduction, Vol. 3, No. 8, pp. 993-998, 1988
© 1988 European Society of Human Reproduction and Embryology
research-article |
Biochemical and pharmacological characterization of human embryo-derived platelet activating factor
Human Reproduction Unit, Royal North Shore Hospital St Leonards, NSW 2065, Australia
The soluble platelet activating factor (PAF) produced by mouse embryos was shown to have properties similar to 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphocholine (PAF-acether). In this study PAF was extracted from the medium In which human embryos were cultured for
18 h prior to transfer. The extracted embryo-derived PAF moved on silica thin layer chromatograms with the same RF of 0.26 ± 0.03 (n = 26) as PAF-acether. Embryo-derived PAF or PAF-acether activity was assayed by monitoring the decrease in the proportion of single platelets in rabbit whole blood due to aggregation on incubation at 37°C. The two agonists were said to be of the same activity, if they induced the same degree of platelet aggregation after 15 min incubation. PAF-acether (93 nM) and embryo-derived PAF of similar activity induced an Identical time response of platelet aggregation, the response being maximal by 6 min. PAF-acether, over the range 5.6200 nM, induced a decrease that was linear when plotted on a log-log scale. Embryo-derived PAF and PAF-acether (184 nM) gave identical dose responses when serially diluted to 16 nM. Pharmacologically, the action of embryo-derived PAF and PAF-acether (46 nM) on platelet aggregation was significantly inhibited by 3.75 µM of the PAF-speeific receptor inhibitor, SRI 63-441, and completely inhibited at 15 µM SRI 63-441. Embryo-derived PAF and PAF-acether (184 nM) were inactivated to the same degree by incubation with 513 IU/ml phospholipase A2 (pA2) Thus, the embryo-derived PAF from the human was shown on the basis of biochemical and pharmacological characterization to be homologous to PAF-acether.
Key words: platelet activating factor (PAF)/PAF-acether
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. O'Neill The potential roles for embryotrophic ligands in preimplantation embryo development Hum. Reprod. Update, May 1, 2008; 14(3): 275 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, V. Chandrakanthan, M. L Day, and C. O'Neill Direct Evidence for the Action of Phosphatidylinositol (3,4,5)-Trisphosphate-Mediated Signal Transduction in the 2-Cell Mouse Embryo Biol Reprod, November 1, 2007; 77(5): 813 - 821. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gopichandran and H. J Leese The effect of paracrine/autocrine interactions on the in vitro culture of bovine preimplantation embryos Reproduction, February 1, 2006; 131(2): 269 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. O'Neill The role of paf in embryo physiology Hum. Reprod. Update, May 1, 2005; 11(3): 215 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Lee, D. Y. Kim, D. H. Nam, S. H. Hyun, G. S. Lee, H. S. Kim, C.-K. Lee, S. K. Kang, B. C. Lee, and W. S. Hwang Role of Messenger RNA Expression of Platelet Activating Factor and Its Receptor in Porcine In Vitro-Fertilized and Cloned Embryo Development Biol Reprod, September 1, 2004; 71(3): 919 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Lu, Y. Li, R. Bathgate, M. Day, and C. O'Neill Ligand-Activated Signal Transduction in the 2-Cell Embryo Biol Reprod, July 1, 2003; 69(1): 106 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.E. Roudebush, J.D. Wininger, A.E. Jones, G. Wright, A.A. Toledo, H.I. Kort, J.B. Massey, and D.B. Shapiro Embryonic platelet-activating factor: an indicator of embryo viability Hum. Reprod., May 1, 2002; 17(5): 1306 - 1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stojanov and C. O'Neill In Vitro Fertilization Causes Epigenetic Modifications to the Onset of Gene Expression from the Zygotic Genome in Mice Biol Reprod, February 1, 2001; 64(2): 696 - 705. [Abstract] [Full Text] |
||||
![]() |
T. Stojanov, S. Alechna, and C. O'Neill In-vitro fertilization and culture of mouse embryos in vitro significantly retards the onset of insulin-like growth factor-II expression from the zygotic genome Mol. Hum. Reprod., February 1, 1999; 5(2): 116 - 124. [Abstract] [Full Text] [PDF] |
||||




